WOBURN, Mass.--(BUSINESS WIRE)--Aphios Corporation today announced that it was granted a Japanese patent for an improved method of inactivating viruses and other pathogens in biologics such as monoclonal antibodies, recombinant therapeutics, human plasma and plasma proteins.
